Last visit was: 18 Nov 2025, 21:15 It is currently 18 Nov 2025, 21:15
Home
GMAT
Messages
Tests
Schools
Events
Rewards
Chat
My Profile
Close
GMAT Club Daily Prep
Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.

Customized
for You

we will pick new questions that match your level based on your Timer History

Track
Your Progress

every week, we’ll send you an estimated GMAT score based on your performance

Practice
Pays

we will pick new questions that match your level based on your Timer History
Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.
Go to My Error Log Learn more
Close
Request Expert Reply
Confirm Cancel
Back to Forum
Create Topic
605-655 Level|   Weaken|      
User avatar
Bunuel
User avatar
Math Expert
Joined: 02 Sep 2009
Last visit: 18 Nov 2025
Posts: 105,355
Own Kudos:
778,095
 [1]
Given Kudos: 99,964
Products:
GMAT Club Tests Forum Quiz
Expert
Expert reply
Active GMAT Club Expert! Tag them with @ followed by their username for a faster response.
Posts: 105,355
Kudos: 778,095
 [1]
Thousands who suffer heart attacks each year die before reaching 13 Nov 2025, 00:30
1
Kudos
Add Kudos
Bookmarks
Bookmark this Post
00:00
Start Timer
Pause Timer
Resume Timer
Show Answer
Hide
Show
History
A
Be sure to select an answer first to save it in the Error Log before revealing the correct answer (OA)!

Difficulty:

45% (medium)

Question Stats:

63% (01:14) correct 37% (01:42) wrong based on 114 sessions

History

Date
Time
Result
Not Attempted Yet
Thousands who suffer heart attacks each year die before reaching a hospital or clinic where they can benefit from the drugs that dissolve clots in coronary arteries. The Food and Drug Administration recently approved a new blood clot dissolving agent, which a spokesman claimed could save the lives of many people who would otherwise join this group of heart attack victims.

Which of the following, if true, would seriously weaken the argument above?

(A) The new agent must be administered by a team of doctors in a hospital or clinic setting.

(B) Many heart attack victims die unnecessarily even though they reach a hospital or clinic in time

(C) The new agent can be effectively administered prior to the victim's arrival at a hospital or clinic

(D) The Food and Drug Administration has already approved agents that are at least as effective as the new drug in dissolving blood clots

(E) The new blood clot dissolving agent causes kidney damage and irregular heart rates in some patients.


ShowHide Answer
Official Answer
A
User avatar
OneLazyBum
User avatar
Joined: 06 Nov 2025
Last visit: 18 Nov 2025
Posts: 24
Own Kudos:
3
 [2]
Given Kudos: 9
Posts: 24
Kudos: 3
 [2]
Thousands who suffer heart attacks each year die before reaching 13 Nov 2025, 02:07
2
Kudos
Add Kudos
Bookmarks
Bookmark this Post
(A)
Because this means that it will not be able to save people who die before reaching the hospital. Therefore, weakens the argument.
User avatar
MansikaVats
User avatar
Joined: 11 Jul 2025
Last visit: 15 Nov 2025
Posts: 5
Own Kudos:
6
 [1]
Given Kudos: 1
Posts: 5
Kudos: 6
 [1]
Thousands who suffer heart attacks each year die before reaching 13 Nov 2025, 05:36
1
Kudos
Add Kudos
Bookmarks
Bookmark this Post
My answer would be option A because the argument lies on how a heart attack patient can be saved even before reaching a hospital by this newly innovated drugs . But if this gets proved that this new agent must be administered by a team of doctors in a hospital then what will even be the use of this new agent .
Hence option A is the correct option in my opinion .

You are free to correct me thanks .
User avatar
Dereno
User avatar
Joined: 22 May 2020
Last visit: 18 Nov 2025
Posts: 744
Own Kudos:
733
 [1]
Given Kudos: 373
Products:
GMAT Club Tests
Posts: 744
Kudos: 733
 [1]
Thousands who suffer heart attacks each year die before reaching 13 Nov 2025, 10:42
1
Kudos
Add Kudos
Bookmarks
Bookmark this Post
Bunuel
Thousands who suffer heart attacks each year die before reaching a hospital or clinic where they can benefit from the drugs that dissolve clots in coronary arteries. The Food and Drug Administration recently approved a new blood clot dissolving agent, which a spokesman claimed could save the lives of many people who would otherwise join this group of heart attack victims.

Which of the following, if true, would seriously weaken the argument above?

(A) The new agent must be administered by a team of doctors in a hospital or clinic setting.

(B) Many heart attack victims die unnecessarily even though they reach a hospital or clinic in time

(C) The new agent can be effectively administered prior to the victim's arrival at a hospital or clinic

(D) The Food and Drug Administration has already approved agents that are at least as effective as the new drug in dissolving blood clots

(E) The new blood clot dissolving agent causes kidney damage and irregular heart rates in some patients.


Show more
Thousands have died before reaching to hospitals or clinics - as they have not got the drugs which is available only at those hospitals/ clinics. Failure to get those drugs will eventually lead to death. The drugs will help in dissolving the clots in coronary arteries. The Food and Drug Administration (FDA) have recently approved a new blood clot dissolving agent ; this could be a game changer as this new entrant will save lives of many.

We need to find a weakener :

(A) The new agent must be administered by a team of doctors in a hospital or clinic setting.

If a new drug can be administered only by a doctor in clinic or hospital setting , this goes back to square one - where the patient is previously administered such drugs only after reaching hospital. The new drug even though having a greater efficacy might fail when not given on time. The crucial golden hour is missed, eventually leading to death of the person. Thus, this is a weakening statement. Hence, correct.

(B) Many heart attack victims die unnecessarily even though they reach a hospital or clinic in time.

The term “ unnecessarily “ is an opened ended statement. This can be interpreted as fate too. Or the patient might have many other complications which could have caused death. This is irrelevant. Hence, wrong.

(C) The new agent can be effectively administered prior to the victim's arrival at a hospital or clinic.

This statement is the exact reverse of Option A, hence being a strengthening statement. It’s wrong.

(D) The Food and Drug Administration has already approved agents that are at least as effective as the new drug in dissolving blood clots.

The option speaks about existence of such agents prior to the new arrival. Thus, a drug being exists doesn’t necessarily mean, they can be administered at the time of need. And, the location criteria clause mentioned needed to administer such drug still remains the same. Hence, wrong.

(E) The new blood clot dissolving agent causes kidney damage and irregular heart rates in some patients.

Complications caused after administering such medication vs the fatality of not administering such drug are two different criteria’s. We are not talking about complications, but new drug applications in general. Hence, wrong.

Option A
Moderators:
GMATNinja
GMAT Club Verbal Expert
7445 posts
GMATNinjaTwo
GMAT Club Verbal Expert
234 posts
miag
188 posts